全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Missed Pancreaticobiliary Malignancy: The Flaw of the Expedited Cholecystectomy

DOI: 10.4236/ss.2024.157042, PP. 451-464

Keywords: Cholecystectomy, Periampullary Malignancy, Pancreas Malignancy, Pancreaticoduodenectomy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: Early cholecystectomy has been recommended for patients with acute cholecystitis and gallstone pancreatitis. However, patients with pancreaticobiliary malignancy may present acutely with similar symptoms. We hypothesize that the diagnoses of these malignancies may potentially be delayed as an unintended consequence of expedited cholecystectomies. This study reviews a cohort of patients who underwent pancreaticoduodenectomy (PD) to identify those who underwent a separate cholecystectomy before their PD. Methods: We retrospectively reviewed 162 PDs performed between 2012 and 2022. Data collected included: demographics, disease etiology and the presence of cholelithiasis. We identified patients who had a previous cholecystectomy and the time elapsed before PD as well as procedures done during the interval. We reported detailed case summaries on those patients who had a cholecystectomy within 1 year of PD. Results: In the entire cohort, mean age was 65 years, 54% were males, and 83% had a malignant reason for PD. Thirty-one patients had cholelithiasis with 23 (14%) patients having had previous cholecystectomy. Six patients had cholecystectomy within 1 year of PD. They had the following malignancies: ampullary—3, pancreas—1, cholangiocarcinoma—1 and neuroendocrine—1. Four of these patients had expedited cholecystectomy on their index hospital admission and were later found to have a periampullary malignancy with further work up. Conclusions: Pancreaticobiliary malignancies can be difficult to diagnose, and surgeons should not overlook these potential diagnoses when considering expedited cholecystectomy. Future studies in large cohorts are needed to identify high risk candidates who should undergo more detailed testing to exclude malignancy before proceeding with cholecystectomy.

References

[1]  Hassler, K.R., Collins, J.T., Philip, K., et al. (2023) Laparoscopic Cholecystectomy. StatPearls.
https://www.ncbi.nlm.nih.gov/books/NBK448145/
[2]  Shaffer, E.A. (2005) Epidemiology and Risk Factors for Gallstone Disease: Has the Paradigm Changed in the 21st Century? Current Gastroenterology Reports, 7, 132-140.
https://doi.org/10.1007/s11894-005-0051-8
[3]  Cao, A.M., Eslick, G.D. and Cox, M.R. (2015) Early Cholecystectomy Is Superior to Delayed Cholecystectomy for Acute Cholecystitis: A Meta-Analysis. Journal of Gastrointestinal Surgery, 19, 848-857.
https://doi.org/10.1007/s11605-015-2747-x
[4]  Gurusamy, K.S. and Samraj, K. (2006) Early versus Delayed Laparoscopic Cholecystectomy for Acute Cholecystitis. The Cochrane Database of Systematic Reviews, No. 4, CD005440.
https://doi.org/10.1002/14651858.CD005440.pub2
[5]  Gurusamy, K.S., Davidson, C., Gluud, C. and Davidson, B.R. (2013) Early versus Delayed Laparoscopic Cholecystectomy for People with Acute Cholecystitis. Cochrane Database of Systematic Reviews, No. 6, CD005440.
https://doi.org/10.1002/14651858.cd005440.pub3
[6]  da Costa, D.W., Bouwense, S.A., Schepers, N.J., Besselink, M.G., van Santvoort, H.C., van Brunschot, S., et al. (2015) Same-Admission versus Interval Cholecystectomy for Mild Gallstone Pancreatitis (PONCHO): A Multicentre Randomised Controlled Trial. The Lancet, 386, 1261-1268.
https://doi.org/10.1016/s0140-6736(15)00274-3
[7]  da Costa, D.W., Dijksman, L.M., Bouwense, S.A., Schepers, N.J., Besselink, M.G., van Santvoort, H.C., et al. (2016) Cost-Effectiveness of Same-Admission versus Interval Cholecystectomy after Mild Gallstone Pancreatitis in the PONCHO Trial. British Journal of Surgery, 103, 1695-1703.
https://doi.org/10.1002/bjs.10222
[8]  Noel, R., Arnelo, U., Lundell, L., Hammarqvist, F., Jumaa, H., Enochsson, L., et al. (2018) Index versus Delayed Cholecystectomy in Mild Gallstone Pancreatitis: Results of a Randomized Controlled Trial. HPB, 20, 932-938.
https://doi.org/10.1016/j.hpb.2018.03.016
[9]  Mueck, K.M., Wei, S., Pedroza, C., Bernardi, K., Jackson, M.L., Liang, M.K., et al. (2019) Gallstone Pancreatitis: Admission versus Normal Cholecystectomy—A Randomized Trial (Gallstone PANC Trial). Annals of Surgery, 270, 519-527.
https://doi.org/10.1097/sla.0000000000003424
[10]  Isbell, K.D., Wei, S., Dodwad, S.M., Avritscher, E.B., Mueck, K.M., Bernardi, K., et al. (2021) Impact of Early Cholecystectomy on the Cost of Treating Mild Gallstone Pancreatitis: Gallstone PANC Trial. Journal of the American College of Surgeons, 233, 517-525.
https://doi.org/10.1016/j.jamcollsurg.2021.06.023
[11]  Liu, J., Wang, Y. and Yu, Y. (2020) Meta-Analysis Reveals an Association between Acute Pancreatitis and the Risk of Pancreatic Cancer. World Journal of Clinical Cases, 8, 4416-4430.
https://doi.org/10.12998/wjcc.v8.i19.4416
[12]  Minato, Y., Kamisawa, T., Tabata, T., Hara, S., Kuruma, S., Chiba, K., et al. (2013) Pancreatic Cancer Causing Acute Pancreatitis: A Comparative Study with Cancer Patients without Pancreatitis and Pancreatitis Patients without Cancer. Journal of Hepato-Biliary-Pancreatic Sciences, 20, 628-633.
https://doi.org/10.1007/s00534-013-0598-y
[13]  Kirkegård, J., Gaber, C., Lund, J.L., Hinton, S.P., Ladekarl, M., Heide-Jørgensen, U., et al. (2020) Acute Pancreatitis as an Early Marker of Pancreatic Cancer and Cancer Stage, Treatment, and Prognosis. Cancer Epidemiology, 64, Article ID: 101647.
https://doi.org/10.1016/j.canep.2019.101647
[14]  Rafiullah, and Tanimu, S. (2014) Adenomyomatous Hyperplasia of the Ampulla of Vater Presenting as Acute Pancreatitis. BMJ Case Reports, 2014, bcr2013203151.
https://doi.org/10.1136/bcr-2013-203151
[15]  Kwon, T., Park, D.H., Shim, K.Y., Cho, H., Park, J.H., Lee, S., et al. (2007) Ampullary Adenomyoma Presenting as Acute Recurrent Pancreatitis. World Journal of Gastroenterology, 13, 2892-2894.
https://doi.org/10.3748/wjg.v13.i20.2892
[16]  Hammarstrom, L., Holmin, T. and Stenram, U. (1997) Adenomyoma of the Ampulla of Vater: An Uncommon Cause of Bile Duct Obstruction. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques, 7, 388-393.
https://doi.org/10.1097/00019509-199710000-00006
[17]  Guzzardo, G., Kleinman, M.S., Krackov, J.H. and Schwartz, S.I. (1990) Recurrent Acute Pancreatitis Caused by Ampullary Villous Adenoma. Journal of Clinical Gastroenterology, 12, 200-202.
https://doi.org/10.1097/00004836-199004000-00020
[18]  Dixon, J.M., Chapman, R.W. and Berry, A.R. (1987) Carcinoid Tumour of the Ampulla of Vater Presenting as Acute Pancreatitis. Gut, 28, 1296-1297.
https://doi.org/10.1136/gut.28.10.1296
[19]  Berk, T., Friedman, L.S., Goldstein, S.D., Marks, G.P. and Rosato, F.E. (1985) Relapsing Acute Pancreatitis as the Presenting Manifestation of an Ampullary Neoplasm in a Patient with Familial Polyposis Coli. The American Journal of Gastroenterology, 80, 627-629.
[20]  Petrou, A., Bramis, K., Williams, T., Papalambros, A., Mantonakis, E. and Felekouras, E. (2011) Acute Recurrent Pancreatitis: A Possible Clinical Manifestation of Ampullary Cancer. JOP: Journal of the Pancreas, 12, 593-597.
[21]  Souaf, I., Znati, K., Chahbouni, S., Hafid, I., Ameurtesse, H., Hammas, N., et al. (2014) Signet Ring Cell Carcinoma of Ampulla of Vater: Report of a Rare Malignancy and Literature Review. Case Reports in Clinical Medicine, 3, 145-148.
https://doi.org/10.4236/crcm.2014.33035
[22]  Petrick, J.L., Yang, B., Altekruse, S.F., Van Dyke, A.L., Koshiol, J., Graubard, B.I., et al. (2017) Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma in the United States: A Population-Based Study in SEER-Medicare. PLOS ONE, 12, e0186643.
https://doi.org/10.1371/journal.pone.0186643
[23]  Tag-Adeen, M., Malak, M., Abdel-Gawad, M., Abu-Elfatth, A., Eldamarawy, R.H., Alzamzamy, A., et al. (2023) Clinical Characteristics, Risk Factors and Diagnostic Outcomes of Patients Presented with Indeterminate Biliary Stricture: A Multicenter Study. Frontiers in Medicine, 9, Article 1018201.
https://doi.org/10.3389/fmed.2022.1018201
[24]  Hashimoto, N. (2016) Prevention and Management of Periampullary Tumors in Familial Adenomatous Polyposis. Open Access Library Journal, 3, 1-5.
https://doi.org/10.4236/oalib.1102338
[25]  Nielson, C.B. and Vincek, V. (2018) Malignant Melanocytic Matricoma and Criteria for Malignancy. Open Journal of Pathology, 8, 94-100.
https://doi.org/10.4236/ojpathology.2018.83011
[26]  Angsuwatcharakon, P., Kulpatcharapong, S., Moon, J.H., Ramchandani, M., Lau, J., Isayama, H., et al. (2022) Consensus Guidelines on the Role of Cholangioscopy to Diagnose Indeterminate Biliary Stricture. HPB, 24, 17-29.
https://doi.org/10.1016/j.hpb.2021.05.005
[27]  Navaneethan, U., Njei, B., Lourdusamy, V., Konjeti, R., Vargo, J.J. and Parsi, M.A. (2015) Comparative Effectiveness of Biliary Brush Cytology and Intraductal Biopsy for Detection of Malignant Biliary Strictures: A Systematic Review and Meta-Analysis. Gastrointestinal Endoscopy, 81, 168-176.
https://doi.org/10.1016/j.gie.2014.09.017
[28]  Buxbaum, J.L., Abbas Fehmi, S.M., Sultan, S., Fishman, D.S., Qumseya, B.J., Cortessis, V.K., et al. (2019) ASGE Guideline on the Role of Endoscopy in the Evaluation and Management of Choledocholithiasis. Gastrointestinal Endoscopy, 89, 1075-1105.E15.
https://doi.org/10.1016/j.gie.2018.10.001
[29]  Singh, A. (2014) Diagnostic Accuracy of MRCP as Compared to Ultrasound/ct in Patients with Obstructive Jaundice. Journal of Clinical and Diagnostic Research, 8, 103-107.
https://doi.org/10.7860/jcdr/2014/8149.4120

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133